Spyryx Biosciences Garners $18,000,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c0762a11-943f-4d16-b924-43f2361f1fad
Date
5/8/2015
Company Name
Spyryx Biosciences
Mailing Address
15 TW Alexander Drive Research Triangle Park, NC 27709 USA
Company Description
Spyryx Biosciences is developing next generation therapeutics for obstructive lung diseases with a particular focus on Cystic Fibrosis and COPD. We are dedicated to making a difference in the lives of patients and their families who bravely face these diseases every day.
Website
http://www.spyryxbio.com
Transaction Type
Venture Equity
Transaction Amount
$18,000,000
Transaction Round
Series A
Proceeds Purposes
The financial strength this money brings to the Company and the significant expertise each of these funds has in pulmonary drug development ideally positions Spyryx to rapidly advance our CF therapeutic into clinical development and to explore the potential for treating COPD.
M&A Terms
Venture Investor
Venture Investor
Venture Investor